ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

Delayed Data
As of Apr 20
 +0.24 / +1.22%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 50.00, with a high estimate of 61.00 and a low estimate of 40.00. The median estimate represents a +151.26% increase from the last price of 19.90.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in ACADIA Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.73%
Growthannually 22.32%


Growthquarterly 18.13%
Growthannually 110.89%
Key to the earnings and sales forecast charts.